[1]SHEN YX,ZHANG H,YAO SH,et al.Methionine oxidation of CLK4 promotes the metabolic switch and redox homeostasis in esophageal carcinoma via inhibiting MITF selective autophagy[J].Clin Transl Med,2022,12(1):e719.
[2]JIA YL,TIAN C,WANG HY,et al.Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin[J].Mol Cancer,2021,20(1):162.
[3]ZOU BB,GUO DH,KONG PZ,et al.Integrative genomic analyses of 1145 patient samples reveal new biomarkers in esophageal squamous cell carcinoma[J].Front Mol Biosci,2021,8:792779.
[4]ZHENG YL,WU JJ,DENG R,et al.G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript[J].Oncogene,2022,41(4):515-526.
[5]GUPTA M,CHANDAN K,SARWAT M.Natural products and their derivatives as immune check point inhibitors:Targeting cytokine/chemokine signalling in cancer[J].Semin Cancer Biol,2022,86(Pt 2):214-232.
[6]WANG HH,WEN CY,CHEN SY,et al.ROS/JNK/C-jun pathway is involved in chaetocin induced colorectal cancer cells apoptosis and macrophage phagocytosis enhancement[J].Front Pharmacol,2021,12:729367.
[7]HE JL,CHEN XX,LI BW,et al.Chaetocin induces cell cycle arrest and apoptosis by regulating the ROS-mediated ASK-1/JNK signaling pathways[J].Oncol Rep,2017,38(4):2489-2497.
[8]LI ZJ,HUANG LH,WEI L,et al.Chaetocin induces caspase-dependent apoptosis in ovarian cancer cells via the generation of reactive oxygen species[J].Oncol Lett,2019,18(2):1915-1921.
[9]WEN CY,WANG HH,WU XB,et al.ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin[J].Cell Death Dis,2019,10(11):809.
[10]LIAO XW,FAN YQ,HOU JH,et al.Identification of chaetocin as a potent non-ROS-mediated anticancer drug candidate for gastric cancer[J].J Cancer,2019,10(16):3678-3690.
[11]HAN XM,HAN Y,ZHENG YS,et al.Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway,and exerts its anti-tumor activity in vivo[J].PLoS One,2017,12(4):e0175950.
[12]ZABINSKY RA,MASON GA,QUEITSCH C,et al.It's not magic - Hsp90 and its effects on genetic and epigenetic variation[J].Semin Cell Dev Biol,2019,88:21-35.
[13]RADLI M,RUDIGER SGD.Dancing with the diva:Hsp90-client interactions[J].J Mol Biol,2018,430(18 Pt B):3029-3040.
[14]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[15]ALLUM WH,STENNING SP,BANCEWICZ J,et al.Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J].J Clin Oncol,2009,27:5062-5067.
[16]KELLY RJ.Emerging multimodality approaches to treat localized esophageal cancer[J].J Natl Compr Canc Netw,2019,17(8):1009-1014.
[17]JIANG HY,LI YQ,XIANG XC,et al.Chaetocin:A review of its anticancer potentials and mechanisms[J].Eur J Pharmacol,2021,910:174459.
[18]SAK A,BANNIK K,GRONEBERG M,et al.Chaetocin induced chromatin condensation:effect on DNA repair signaling and survival[J].Int J Radiat Biol,2021,97(4):494-506.
[19]LIU XF,GUO S,LIU XG,et al.Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells[J].Apoptosis,2015,20(11):1499-1507.
[20]LEAL-ESTEBAN LC,FAJAS L.Cell cycle regulators in cancer cell metabolism[J].Biochim Biophys Acta Mol Basis Dis,2020,1866(5):165715.
[21]HENDZEL MJ,WEI Y,MANCINI MA,et al.Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation[J].Chromosoma,1997,106(6):348-360.
[22]MAKHNEVYCH T,HOURY WA.The role of Hsp90 in protein complex assembly[J].Biochim Biophys Acta,2012,1823(3):674-682.
[23]LI J,BUCHNER J.Structure,function and regulation of the hsp90 machinery[J].Biomed J,2013,36(3):106-117.
[24]BIRBO B,MADU EE,MADU CO,et al.Role of HSP90 in cancer[J].Int J Mol Sci,2021,22(19):10317.
[25]DUTTA GUPTA S,BOMMAKA MK,BANERJEE A.Inhibiting protein-protein interactions of Hsp90 as a novel approach for targeting cancer[J].Eur J Med Chem,2019,178:48-63.
[26]TALAEI S,MELLATYAR H,ASADI A,et al.Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment[J].Chem Biol Drug Des,2019,93(5):760-786.
[27]DONNELLY A,BLAGG BS.Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket[J].Curr Med Chem,2008,15(26):2702-2717.